New Jersey (United States) – A2Z Market Research published new research on Global Artificial Intelligence Drug R&D covering the micro-level of analysis by competitors and key business segments (2022-2029). The Global Artificial Intelligence Drug R&D explores a comprehensive study on various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing. Various factors are responsible for the market's growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Artificial Intelligence Drug R&D market.